Wang EX - Search Results

1

Effects of methionine deficiency on B7H3-DAP12-CAR-T cells in the treatment of lung squamous cell carcinoma.

Yu T, Nie FQ, Zhang Q, Yu SK, Zhang ML, Wang Q, Wang EX, Lu KH, Sun M. Yu T, et al. Among authors: wang ex. Cell Death Dis. 2024 Jan 5;15(1):12. doi: 10.1038/s41419-023-06376-w. Cell Death Dis. 2024. PMID: 38182561 Free PMC article.

2

Novel two-chain structure utilizing KIRS2/DAP12 domain improves the safety and efficacy of CAR-T cells in adults with r/r B-ALL.

Sun M, Xu P, Wang E, Zhou M, Xu T, Wang J, Wang Q, Wang B, Lu K, Wang C, Chen B. Sun M, et al. Mol Ther Oncolytics. 2021 Aug 28;23:96-106. doi: 10.1016/j.omto.2021.08.014. eCollection 2021 Dec 17. Mol Ther Oncolytics. 2021. PMID: 34703879 Free PMC article.

3

Coexpression of c-Jun in multiple-chain DAP-CAR-engineered T-cells for solid tumor therapy.

Xu T, Wang C, Chen X, Bai J, Wang E, Sun M. Xu T, et al. Immunotherapy. 2022 Dec;14(18):1457-1466. doi: 10.2217/imt-2022-0171. Epub 2023 Jan 4. Immunotherapy. 2022. PMID: 36597720

4

A novel TREM1/DAP12-based multiple chain CAR-T cell targets PTK7 in ovarian cancer therapy.

Xu T, Wang C, Wang X, Wang E, Wang B, Sun M. Xu T, et al. Med Oncol. 2023 Jul 5;40(8):226. doi: 10.1007/s12032-023-02084-9. Med Oncol. 2023. PMID: 37405498

5

TREM1/DAP12 based novel multiple chain CAR-T cells targeting DLL3 show robust anti-tumour efficacy for small cell lung cancer.

Nie F, Chen Y, Hu Y, Huang P, Shi X, Cai J, Qiu M, Wang E, Lu K, Sun M. Nie F, et al. Immunology. 2024 Mar 12. doi: 10.1111/imm.13776. Online ahead of print. Immunology. 2024. PMID: 38469682

6

TREM1/Dap12-based CAR-T cells show potent antitumor activity.

Chen B, Zhou M, Zhang H, Wang C, Hu X, Wang B, Wang E. Chen B, et al. Immunotherapy. 2019 Aug;11(12):1043-1055. doi: 10.2217/imt-2019-0017. Epub 2019 Jul 3. Immunotherapy. 2019. PMID: 31268375

7

Pseudoprogression of extramedullary disease in relapsed acute lymphoblastic leukemia after CAR T-cell therapy.

Huang J, Rong L, Wang E, Fang Y. Huang J, et al. Immunotherapy. 2021 Jan;13(1):5-10. doi: 10.2217/imt-2020-0188. Epub 2020 Oct 12. Immunotherapy. 2021. PMID: 33045890

8

The Landscape of Cell and Gene Therapies for Solid Tumors.

Wang S, Sun F, Huang H, Chen K, Li QJ, Zhang L, Wang E, Wang C, Zhang H, Yuan AQ, Chen B, Deng T, Liu Y, Sun J, Liu D, Yu Y, Fang Y, Jiang N, Wu D, Fang H, Bai Y, Xing S, Ni Y, Fan Q, Yu A, Sun C, Tang Y, Li N, Xu B, He J. Wang S, et al. Cancer Cell. 2021 Jan 11;39(1):7-8. doi: 10.1016/j.ccell.2020.12.005. Cancer Cell. 2021. PMID: 33434513 Free article. No abstract available.

9

Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors.

Wang E, Wang LC, Tsai CY, Bhoj V, Gershenson Z, Moon E, Newick K, Sun J, Lo A, Baradet T, Feldman MD, Barrett D, Puré E, Albelda S, Milone MC. Wang E, et al. Cancer Immunol Res. 2015 Jul;3(7):815-26. doi: 10.1158/2326-6066.CIR-15-0054. Epub 2015 May 4. Cancer Immunol Res. 2015. PMID: 25941351 Free PMC article.

10

The Scaffold Protein KATNIP Enhances CILK1 Control of Primary Cilia.

Turner JS, McCabe EA, Kuang KW, Gailey CD, Brautigan DL, Limerick A, Wang EX, Fu Z. Turner JS, et al. Among authors: wang ex. Mol Cell Biol. 2023;43(9):472-480. doi: 10.1080/10985549.2023.2246870. Epub 2023 Sep 4. Mol Cell Biol. 2023. PMID: 37665596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page